Syngo Carbon Clinicals

Syngo Carbon Clinicals is a software plug-in designed to enhance medical image analysis by providing advanced visualization and quantitative tools for diagnostic support within existing imaging platforms. It employs specialized algorithms, including deep learning for organ segmentation and semi-automated lesion quantification, to assist clinicians in evaluating data from modalities like CT and MR, particularly in oncological assessments.

Syngo Carbon Clinicals is a software-only medical device that functions as a plug-in for existing SYNGO-based medical imaging viewing applications. It aims to augment diagnostic reading by providing a collection of advanced imaging tools that allow healthcare professionals to prepare, process, evaluate, manipulate, and communicate clinical data derived from medical imaging modalities such as CT and MR. The system is designed to support technicians and physicians by facilitating qualitative and quantitative measurements and the analysis of clinical data, integrating into their workflows to generate supplementary results or renderings through the host application. The device incorporates several technological features, including 'Cinematic insight' for advanced cinematic rendering of anatomical structures, which utilizes deep learning for organ segmentation and cinematic volume rendering techniques. It also offers 'Manual Calibration' to enable measurements on non-calibrated images. For oncology, 'Basic Onco Tools' are provided, such as 'Assisted Perpendicular' for diameter measurements, 'Lesion Quantification' for semi-automatic lesion segmentation and measurement, and 'Lung Nodule Marker' for evaluating lung lesions, including their changes over time. Syngo Carbon Clinicals depends on the hosting application for many fundamental operations like image communication, basic display, operating system environment, cybersecurity measures, and the primary user interface, focusing its own capabilities on specialized image processing and analysis tools.

AI Regulatory Concerns

Powered by

Jev reads the full FDA letter and returns calibrated concern probabilities per regulatory category. These are AI estimates, not regulatory advice.

• Q1. How does the performance of the 'Cinematic insight' tool's organ segmentation vary across different CT and MR image acquisition parameters and patient anatomies?; What specific quantitative benchmarks define the acceptable performance for the 'Lesion Quantification' tool, especially concerning its semi-automatic segmentation accuracy?; Can the 'Lung Nodule Marker' tool integrate with existing LIDC/Lung-RADS classification systems to streamline reporting?; What are the computational requirements for running Syngo Carbon Clinicals, and how do they scale with the complexity of the imaging data and the number of tools used simultaneously within a hosting application?; How does the 'Manual Calibration' tool account for potential geometric distortions in images from different modalities or acquisition protocols to ensure measurement accuracy?